A single dose of SARS-CoV-2 FINLAY-FR-1A dimeric-RBD recombinant vaccine enhances neutralization response in COVID-19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial
Arturo Chang-Monteagudo, View ORCID ProfileRolando Ochoa-Azze, Yanet Climent-Ruiz, View ORCID ProfileConsuelo Macías-Abraham, Laura Rodríguez-Noda, View ORCID ProfileCarmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Rocmira Perez-Nicado, Raúl González-Mugica, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María de los A. García-García, Yanet Jerez-Barceló, Yenisey Triana-Marrero, Laura Ruiz-Villegas, Luis Rodríguez-Prieto, Rinaldo Puga-Gómez, Pedro Pablo Guerra-Chaviano, Yaíma Zúñiga-Rosales, Beatriz Marcheco-Teruel, Mireida Rodríguez-Acosta, Enrique Noa-Romero, Juliet Enríquez-Puertas, Delia Porto-González, Kalet Leon-Monzon, Guan-Wu Chen, Luis Herrera Martinez, View ORCID ProfileYury Valdés-Balbín, View ORCID ProfileDagmar García-Rivera, View ORCID ProfileVicente Vérez-Bencomo, The Soberana 01B Clinical Trial team
doi: https://doi.org/10.1101/2021.02.22.21252091
Arturo Chang-Monteagudo
1Institute of Hematology and Immunology, Havana, Cuba
Rolando Ochoa-Azze
2Finlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba
Yanet Climent-Ruiz
2Finlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba
Consuelo Macías-Abraham
1Institute of Hematology and Immunology, Havana, Cuba
Laura Rodríguez-Noda
2Finlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba
Carmen Valenzuela-Silva
3Center of Molecular Immunology, P.O. Box 16040, 216 St. Havana, Cuba
Belinda Sánchez-Ramírez
3Center of Molecular Immunology, P.O. Box 16040, 216 St. Havana, Cuba
Rocmira Perez-Nicado
2Finlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba
Raúl González-Mugica
2Finlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba
Tays Hernández-García
3Center of Molecular Immunology, P.O. Box 16040, 216 St. Havana, Cuba
Ivette Orosa-Vázquez
3Center of Molecular Immunology, P.O. Box 16040, 216 St. Havana, Cuba
Marianniz Díaz-Hernández
3Center of Molecular Immunology, P.O. Box 16040, 216 St. Havana, Cuba
María de los A. García-García
1Institute of Hematology and Immunology, Havana, Cuba
Yanet Jerez-Barceló
1Institute of Hematology and Immunology, Havana, Cuba
Yenisey Triana-Marrero
1Institute of Hematology and Immunology, Havana, Cuba
Laura Ruiz-Villegas
1Institute of Hematology and Immunology, Havana, Cuba
Luis Rodríguez-Prieto
1Institute of Hematology and Immunology, Havana, Cuba
Rinaldo Puga-Gómez
4Cira Garcia Clinic, Calle 20 NO. 4101 esq. a Av. 41 Miramar, La Habana
Pedro Pablo Guerra-Chaviano
5National Center for Coordination of Clinical Trial (CENCEC) Calle 5ta A e/ 60 y 62 Miramar, Playa, CP 11300, La Habana, Cuba
Yaíma Zúñiga-Rosales
6National Center of Medical Genetics, Ave. 31 Esq.146 No 3102, Reparto Cubanacán CP. 11400
Beatriz Marcheco-Teruel
6National Center of Medical Genetics, Ave. 31 Esq.146 No 3102, Reparto Cubanacán CP. 11400
Mireida Rodríguez-Acosta
7National Civil Defense Research Laboratory, Cuba
Enrique Noa-Romero
7National Civil Defense Research Laboratory, Cuba
Juliet Enríquez-Puertas
7National Civil Defense Research Laboratory, Cuba
Delia Porto-González
8National Blood Program, Ministry of Health, Cuba
Kalet Leon-Monzon
3Center of Molecular Immunology, P.O. Box 16040, 216 St. Havana, Cuba
Guan-Wu Chen
9Chengdu Olisynn Biotech. Co. Ltd., and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China
Luis Herrera Martinez
10Biocubafarma, Ave. Independencia #8126, esq. a Calle 100. Boyeros. La Habana. Cuba
Yury Valdés-Balbín
1Institute of Hematology and Immunology, Havana, Cuba
Dagmar García-Rivera
1Institute of Hematology and Immunology, Havana, Cuba
Vicente Vérez-Bencomo
1Institute of Hematology and Immunology, Havana, Cuba
Article usage
Posted March 03, 2021.
A single dose of SARS-CoV-2 FINLAY-FR-1A dimeric-RBD recombinant vaccine enhances neutralization response in COVID-19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial
Arturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Laura Rodríguez-Noda, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Rocmira Perez-Nicado, Raúl González-Mugica, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María de los A. García-García, Yanet Jerez-Barceló, Yenisey Triana-Marrero, Laura Ruiz-Villegas, Luis Rodríguez-Prieto, Rinaldo Puga-Gómez, Pedro Pablo Guerra-Chaviano, Yaíma Zúñiga-Rosales, Beatriz Marcheco-Teruel, Mireida Rodríguez-Acosta, Enrique Noa-Romero, Juliet Enríquez-Puertas, Delia Porto-González, Kalet Leon-Monzon, Guan-Wu Chen, Luis Herrera Martinez, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo, The Soberana 01B Clinical Trial team
medRxiv 2021.02.22.21252091; doi: https://doi.org/10.1101/2021.02.22.21252091
A single dose of SARS-CoV-2 FINLAY-FR-1A dimeric-RBD recombinant vaccine enhances neutralization response in COVID-19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial
Arturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Laura Rodríguez-Noda, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Rocmira Perez-Nicado, Raúl González-Mugica, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María de los A. García-García, Yanet Jerez-Barceló, Yenisey Triana-Marrero, Laura Ruiz-Villegas, Luis Rodríguez-Prieto, Rinaldo Puga-Gómez, Pedro Pablo Guerra-Chaviano, Yaíma Zúñiga-Rosales, Beatriz Marcheco-Teruel, Mireida Rodríguez-Acosta, Enrique Noa-Romero, Juliet Enríquez-Puertas, Delia Porto-González, Kalet Leon-Monzon, Guan-Wu Chen, Luis Herrera Martinez, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo, The Soberana 01B Clinical Trial team
medRxiv 2021.02.22.21252091; doi: https://doi.org/10.1101/2021.02.22.21252091
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2821)
- Dermatology (242)
- Emergency Medicine (425)
- Epidemiology (12513)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4387)
- Geriatric Medicine (399)
- Health Economics (711)
- Health Informatics (2829)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4149)
- Nursing (220)
- Nutrition (614)
- Oncology (2186)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6732)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)